🇺🇸 FDA
Patent

US 12188039

Recombinant adeno-associated viral vector for gene delivery

granted A61KA61K38/00A61K48/005

Quick answer

US patent 12188039 (Recombinant adeno-associated viral vector for gene delivery) held by The Board of Regents of the University of Texas System expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61K48/005, A61K48/0075, A61P